Krishnamurthy Malathi Selected Research

Endoribonucleases

1/2020	RNase L Amplifies Interferon Signaling by Inducing Protein Kinase R-Mediated Antiviral Stress Granules.
3/2017	RNase L Suppresses Androgen Receptor Signaling, Cell Migration and Matrix Metalloproteinase Activity in Prostate Cancer Cells.
10/2014	RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Krishnamurthy Malathi Research Topics

Disease

9	Virus Diseases (Viral Diseases) 01/2021 - 10/2005
7	Prostatic Neoplasms (Prostate Cancer) 03/2017 - 12/2004
5	Infections 01/2020 - 03/2006
4	Neoplasms (Cancer) 03/2017 - 10/2005
2	familial Prostate cancer 10/2005 - 12/2004
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 03/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2014
1	Melanoma (Melanoma, Malignant) 08/2007
1	Carcinoma (Carcinomatosis) 03/2006
1	Immune System Diseases (Immune Disorders) 11/2005
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2004

Drug/Important Bio-Agent (IBA)

14	2-5A-dependent ribonuclease (RNase L)IBA 01/2021 - 12/2004
9	Antiviral Agents (Antivirals)IBA 01/2021 - 12/2004
6	InterferonsIBA 01/2021 - 12/2004
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2004
5	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2005
3	EndoribonucleasesIBA 01/2020 - 10/2014
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2014
2	LigandsIBA 01/2020 - 12/2004
2	Androgen Receptors (Androgen Receptor)IBA 03/2017 - 01/2007
2	Pharmaceutical PreparationsIBA 12/2014 - 10/2005
2	EnzymesIBA 12/2014 - 01/2007
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Interferon Type IIBA 01/2021
1	Viral ProteinsIBA 01/2020
1	IFIH1 Interferon-Induced HelicaseIBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020
1	Viral RNAIBA 01/2020
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Pattern Recognition ReceptorsIBA 01/2020
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020
1	ChromatinIBA 10/2017
1	RNA Polymerase II (RNA Polymerase B)IBA 10/2017
1	Botulinum Toxins (Botulinum Toxin)IBA 03/2017
1	IntegrinsIBA 03/2017
1	Matrix Metalloproteinases (MMPs)IBA 03/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 03/2017
1	Double-Stranded RNA (RNA, Double Stranded)IBA 12/2014
1	Streptozocin (Streptozotocin)FDA Link 12/2014
1	Insulin (Novolin)FDA Link 12/2014
1	Poly I-CIBA 12/2014
1	2',5'-oligoadenylate (PAPAPA)IBA 10/2014
1	FilaminsIBA 10/2014
1	Toll-Like Receptor 9IBA 01/2014
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	CPG-oligonucleotideIBA 01/2014
1	CytokinesIBA 01/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	ChemokinesIBA 01/2014
1	Ribonucleases (Ribonuclease)IBA 12/2012
1	RNA Helicases (RNA Helicase)IBA 08/2007
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 08/2007
1	transcription factor NF-AT c3IBA 01/2007
1	Transcription Factors (Transcription Factor)IBA 01/2007
1	DNA (Deoxyribonucleic Acid)IBA 01/2007
1	Nucleic AcidsIBA 03/2006
1	Phosphatidylethanolamine Binding ProteinIBA 01/2006
1	2',5'-Oligoadenylate Synthetase (2',5' Oligoadenylate Synthetase)IBA 01/2006
1	Carrier Proteins (Binding Protein)IBA 01/2006
1	Peptides (Polypeptides)IBA 11/2005
1	Biological ProductsIBA 10/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2005
1	Growth Differentiation Factor 15IBA 10/2005
1	Complementary DNA (cDNA)IBA 10/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2004
1	Small Interfering RNA (siRNA)IBA 12/2004
1	trioctyl phosphine oxide (TOPO)IBA 12/2004
1	Topoisomerase I InhibitorsIBA 12/2004
1	CholesterolIBA 02/2004
1	SphingolipidsIBA 02/2004

Therapy/Procedure

1	Therapeutics 11/2005